Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy
この論文をさがす
説明
In diabetic nephropathy (DN), possible mediators of untoward effects of hyperglycemia include the advanced glycation end products (AGEs). Indeed, an AGE, carboxymethyllysine (CML), accumulates in expanded mesangial matrix and nodular lesions. An advanced lipoxidation end product (ALE), malondialdehyde-lysine (MDA-lysine), generated on proteins during lipid peroxidation also accumulates in these lesions. As both ALEs and AGEs are formed by carbonyl amine chemistry between protein and carbonyl compounds derived from autoxidation of lipids and carbohydrates, their colocalization suggests an increased carbonyl modification of proteins.To address this hypothesis, human diabetic renal tissues were examined to characterize carbonyl modification of proteins by lipids and carbohydrates: (a) ALEs, MDA-lysine and 4-hydroxynonenal (HNE) protein adduct, derived from lipids, and (b) AGEs, pentosidine and CML, derived from carbohydrates. Furthermore, to elucidate the biological effect of carbonyl modification on primary cultured human and rat mesangial cells, the intracellular protein phosphorylation was examined in the presence of various kinds of carbonyl compounds.The ALE and AGE adducts examined were identified in expanded mesangial matrix and nodular lesions. The exposure of cultured mesangial cells to carbonyl compounds resulted in phosphorylation of tyrosine residues of a number of intracellular proteins.These data suggest a broad derangement in nonenzymatic biochemistry involving both lipids and carbohydrates exists in diabetic glomerular lesions ("carbonyl stress").
収録刊行物
-
- Kidney Int
-
Kidney Int 56 (7), 54-56, 1999
Elsevier BV
- Tweet
キーワード
- Glycation End Products, Advanced
- diabetes
- advanced glycation end products
- Lysine
- Kidney Glomerulus
- advanced lipoxidation end product
- oxidative protein damage
- Lipid Metabolism
- reactive carbonyl compound
- Immunohistochemistry
- Rats
- Nephrology
- Malondialdehyde
- Animals
- Carbohydrate Metabolism
- Humans
- Diabetic Nephropathies
- Lipid Peroxidation
- Oxidation-Reduction
- Cells, Cultured
詳細情報 詳細情報について
-
- CRID
- 1572543025925327232
-
- NII論文ID
- 30014586569
-
- ISSN
- 00852538
-
- PubMed
- 10412738
-
- データソース種別
-
- CiNii Articles
- OpenAIRE